NasdaqCM - Delayed Quote USD
Adverum Biotechnologies, Inc. (ADVM)
At close: November 5 at 4:00 PM EST
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
173,010.00
308,372.00
439,727.00
482,567.00
Total Liabilities Net Minority Interest
89,541.00
126,854.00
123,542.00
48,220.00
Total Equity Gross Minority Interest
83,469.00
181,518.00
316,185.00
434,347.00
Total Capitalization
83,469.00
181,518.00
316,185.00
434,347.00
Common Stock Equity
83,469.00
181,518.00
316,185.00
434,347.00
Capital Lease Obligations
75,036.00
106,802.00
102,994.00
30,708.00
Net Tangible Assets
83,469.00
181,518.00
316,185.00
434,347.00
Working Capital
77,859.00
158,349.00
295,825.00
413,567.00
Invested Capital
83,469.00
181,518.00
316,185.00
434,347.00
Tangible Book Value
83,469.00
181,518.00
316,185.00
434,347.00
Total Debt
75,036.00
106,802.00
102,994.00
30,708.00
Share Issued
10,143.30
10,011.70
9,838.10
9,754.90
Ordinary Shares Number
10,143.30
10,011.70
9,838.10
9,754.90
12/31/2020 - 7/31/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ORIC ORIC Pharmaceuticals, Inc.
9.68
+2.11%
FDMT 4D Molecular Therapeutics, Inc.
8.39
+2.63%
ALEC Alector, Inc.
4.9950
-5.22%
SLDB Solid Biosciences Inc.
5.94
+4.95%
ALDX Aldeyra Therapeutics, Inc.
5.27
+1.74%
RGNX REGENXBIO Inc.
8.92
+1.83%
OPT Opthea Limited
4.1900
-1.87%
REPL Replimune Group, Inc.
12.02
0.00%
STOK Stoke Therapeutics, Inc.
13.05
-0.38%
ANAB AnaptysBio, Inc.
19.88
-0.30%